N-[(5-methoxy-6-oxo-1H-pyrimidin-2-yl)methyl]-2-(6-morpholin-4-yl-2-pyridin-2-ylpurin-7-yl)acetamide;6-methyl-2-pyridin-2-ylthieno[3,2-d]pyrimidin-4-amine;2-(6-morpholin-4-yl-2-pyridin-2-ylpurin-7-yl)acetamide;7-phenyl-2-pyridin-2-ylthieno[3,2-d]pyrimidin-4-amine;4-[2-pyridin-2-yl-5-(trifluoromethyl)thieno[2,3-d]pyrimidin-4-yl]morpholine

C83H75F3N28O7S3 — CID 160558567

IUPACN-[(5-methoxy-6-oxo-1H-pyrimidin-2-yl)methyl]-2-(6-morpholin-4-yl-2-pyridin-2-ylpurin-7-yl)acetamide;6-methyl-2-pyridin-2-ylthieno[3,2-d]pyrimidin-4-amine;2-(6-morpholin-4-yl-2-pyridin-2-ylpurin-7-yl)acetamide;7-phenyl-2-pyridin-2-ylthieno[3,2-d]pyrimidin-4-amine;4-[2-pyridin-2-yl-5-(trifluoromethyl)thieno[2,3-d]pyrimidin-4-yl]morpholine
SMILESCOc1cnc(CNC(=O)Cn2cnc3nc(-c4ccccn4)nc(N4CCOCC4)c32)[nH]c1=O.Cc1cc2nc(-c3ccccn3)nc(N)c2s1.FC(F)(F)c1csc2nc(-c3ccccn3)nc(N3CCOCC3)c12.NC(=O)Cn1cnc2nc(-c3ccccn3)nc(N3CCOCC3)c21.Nc1nc(-c2ccccn2)nc2c(-c3ccccc3)csc12
InChIInChI=1S/C22H23N9O4.C17H12N4S.C16H13F3N4OS.C16H17N7O2.C12H10N4S/c1-34-15-10-24-16(27-22(15)33)11-25-17(32)12-31-13-26-20-18(31)21(30-6-8-35-9-7-30)29-19(28-20)14-4-2-3-5-23-14;18-16-15-14(12(10-22-15)11-6-2-1-3-7-11)20-17(21-16)13-8-4-5-9-19-13;17-16(18,19)10-9-25-15-12(10)14(23-5-7-24-8-6-23)21-13(22-15)11-3-1-2-4-20-11;17-12(24)9-23-10-19-15-13(23)16(22-5-7-25-8-6-22)21-14(20-15)11-3-1-2-4-18-11;1-7-6-9-10(17-7)11(13)16-12(15-9)8-4-2-3-5-14-8/h2-5,10,13H,6-9,11-12H2,1H3,(H,25,32)(H,24,27,33);1-10H,(H2,18,20,21);1-4,9H,5-8H2;1-4,10H,5-9H2,(H2,17,24);2-6H,1H3,(H2,13,15,16)
InChIKeyQYZXIRRBYACBRC-UHFFFAOYSA-N
MW1729.90 g/mol
LogP10.60
Rot. Bonds16

About N-[(5-methoxy-6-oxo-1H-pyrimidin-2-yl)methyl]-2-(6-morpholin-4-yl-2-pyridin-2-ylpurin-7-yl)acetamide;6-methyl-2-pyridin-2-ylthieno[3,2-d]pyrimidin-4-amine;2-(6-morpholin-4-yl-2-pyridin-2-ylpurin-7-yl)acetamide;7-phenyl-2-pyridin-2-ylthieno[3,2-d]pyrimidin-4-amine;4-[2-pyridin-2-yl-5-(trifluoromethyl)thieno[2,3-d]pyrimidin-4-yl]morpholine

N-[(5-methoxy-6-oxo-1H-pyrimidin-2-yl)methyl]-2-(6-morpholin-4-yl-2-pyridin-2-ylpurin-7-yl)acetamide;6-methyl-2-pyridin-2-ylthieno[3,2-d]pyrimidin-4-amine;2-(6-morpholin-4-yl-2-pyridin-2-ylpurin-7-yl)acetamide;7-phenyl-2-pyridin-2-ylthieno[3,2-d]pyrimidin-4-amine;4-[2-pyridin-2-yl-5-(trifluoromethyl)thieno[2,3-d]pyrimidin-4-yl]morpholine (PubChem CID 160558567) has the molecular formula C83H75F3N28O7S3 and a molecular weight of 1729.90 g/mol. Its IUPAC name is N-[(5-methoxy-6-oxo-1H-pyrimidin-2-yl)methyl]-2-(6-morpholin-4-yl-2-pyridin-2-ylpurin-7-yl)acetamide;6-methyl-2-pyridin-2-ylthieno[3,2-d]pyrimidin-4-amine;2-(6-morpholin-4-yl-2-pyridin-2-ylpurin-7-yl)acetamide;7-phenyl-2-pyridin-2-ylthieno[3,2-d]pyrimidin-4-amine;4-[2-pyridin-2-yl-5-(trifluoromethyl)thieno[2,3-d]pyrimidin-4-yl]morpholine.

Molecular Properties

Compound NameN-[(5-methoxy-6-oxo-1H-pyrimidin-2-yl)methyl]-2-(6-morpholin-4-yl-2-pyridin-2-ylpurin-7-yl)acetamide;6-methyl-2-pyridin-2-ylthieno[3,2-d]pyrimidin-4-amine;2-(6-morpholin-4-yl-2-pyridin-2-ylpurin-7-yl)acetamide;7-phenyl-2-pyridin-2-ylthieno[3,2-d]pyrimidin-4-amine;4-[2-pyridin-2-yl-5-(trifluoromethyl)thieno[2,3-d]pyrimidin-4-yl]morpholine
PubChem CID160558567
Molecular FormulaC83H75F3N28O7S3
Molecular Weight1729.90 g/mol
Exact Mass1728.55
IUPAC NameN-[(5-methoxy-6-oxo-1H-pyrimidin-2-yl)methyl]-2-(6-morpholin-4-yl-2-pyridin-2-ylpurin-7-yl)acetamide;6-methyl-2-pyridin-2-ylthieno[3,2-d]pyrimidin-4-amine;2-(6-morpholin-4-yl-2-pyridin-2-ylpurin-7-yl)acetamide;7-phenyl-2-pyridin-2-ylthieno[3,2-d]pyrimidin-4-amine;4-[2-pyridin-2-yl-5-(trifluoromethyl)thieno[2,3-d]pyrimidin-4-yl]morpholine
SMILESCOc1cnc(CNC(=O)Cn2cnc3nc(-c4ccccn4)nc(N4CCOCC4)c32)[nH]c1=O.Cc1cc2nc(-c3ccccn3)nc(N)c2s1.FC(F)(F)c1csc2nc(-c3ccccn3)nc(N3CCOCC3)c12.NC(=O)Cn1cnc2nc(-c3ccccn3)nc(N3CCOCC3)c21.Nc1nc(-c2ccccn2)nc2c(-c3ccccc3)csc12
InChIInChI=1S/C22H23N9O4.C17H12N4S.C16H13F3N4OS.C16H17N7O2.C12H10N4S/c1-34-15-10-24-16(27-22(15)33)11-25-17(32)12-31-13-26-20-18(31)21(30-6-8-35-9-7-30)29-19(28-20)14-4-2-3-5-23-14;18-16-15-14(12(10-22-15)11-6-2-1-3-7-11)20-17(21-16)13-8-4-5-9-19-13;17-16(18,19)10-9-25-15-12(10)14(23-5-7-24-8-6-23)21-13(22-15)11-3-1-2-4-20-11;17-12(24)9-23-10-19-15-13(23)16(22-5-7-25-8-6-22)21-14(20-15)11-3-1-2-4-18-11;1-7-6-9-10(17-7)11(13)16-12(15-9)8-4-2-3-5-14-8/h2-5,10,13H,6-9,11-12H2,1H3,(H,25,32)(H,24,27,33);1-10H,(H2,18,20,21);1-4,9H,5-8H2;1-4,10H,5-9H2,(H2,17,24);2-6H,1H3,(H2,13,15,16)
InChIKeyQYZXIRRBYACBRC-UHFFFAOYSA-N
XLogP10.60
TPSA445.61 Ų
H-Bond Donors5
H-Bond Acceptors35
Rotatable Bonds16
Heavy Atoms124
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5001729.90
LogP ≤ 510.60
H-Bond Donors ≤ 55
H-Bond Acceptors ≤ 1035

Analyze N-[(5-methoxy-6-oxo-1H-pyrimidin-2-yl)methyl]-2-(6-morpholin-4-yl-2-pyridin-2-ylpurin-7-yl)acetamide;6-methyl-2-pyridin-2-ylthieno[3,2-d]pyrimidin-4-amine;2-(6-morpholin-4-yl-2-pyridin-2-ylpurin-7-yl)acetamide;7-phenyl-2-pyridin-2-ylthieno[3,2-d]pyrimidin-4-amine;4-[2-pyridin-2-yl-5-(trifluoromethyl)thieno[2,3-d]pyrimidin-4-yl]morpholine with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of N-[(5-methoxy-6-oxo-1H-pyrimidin-2-yl)methyl]-2-(6-morpholin-4-yl-2-pyridin-2-ylpurin-7-yl)acetamide;6-methyl-2-pyridin-2-ylthieno[3,2-d]pyrimidin-4-amine;2-(6-morpholin-4-yl-2-pyridin-2-ylpurin-7-yl)acetamide;7-phenyl-2-pyridin-2-ylthieno[3,2-d]pyrimidin-4-amine;4-[2-pyridin-2-yl-5-(trifluoromethyl)thieno[2,3-d]pyrimidin-4-yl]morpholine?
The IUPAC name of N-[(5-methoxy-6-oxo-1H-pyrimidin-2-yl)methyl]-2-(6-morpholin-4-yl-2-pyridin-2-ylpurin-7-yl)acetamide;6-methyl-2-pyridin-2-ylthieno[3,2-d]pyrimidin-4-amine;2-(6-morpholin-4-yl-2-pyridin-2-ylpurin-7-yl)acetamide;7-phenyl-2-pyridin-2-ylthieno[3,2-d]pyrimidin-4-amine;4-[2-pyridin-2-yl-5-(trifluoromethyl)thieno[2,3-d]pyrimidin-4-yl]morpholine (CID 160558567) is N-[(5-methoxy-6-oxo-1H-pyrimidin-2-yl)methyl]-2-(6-morpholin-4-yl-2-pyridin-2-ylpurin-7-yl)acetamide;6-methyl-2-pyridin-2-ylthieno[3,2-d]pyrimidin-4-amine;2-(6-morpholin-4-yl-2-pyridin-2-ylpurin-7-yl)acetamide;7-phenyl-2-pyridin-2-ylthieno[3,2-d]pyrimidin-4-amine;4-[2-pyridin-2-yl-5-(trifluoromethyl)thieno[2,3-d]pyrimidin-4-yl]morpholine.
What is the SMILES notation for N-[(5-methoxy-6-oxo-1H-pyrimidin-2-yl)methyl]-2-(6-morpholin-4-yl-2-pyridin-2-ylpurin-7-yl)acetamide;6-methyl-2-pyridin-2-ylthieno[3,2-d]pyrimidin-4-amine;2-(6-morpholin-4-yl-2-pyridin-2-ylpurin-7-yl)acetamide;7-phenyl-2-pyridin-2-ylthieno[3,2-d]pyrimidin-4-amine;4-[2-pyridin-2-yl-5-(trifluoromethyl)thieno[2,3-d]pyrimidin-4-yl]morpholine?
The canonical SMILES for N-[(5-methoxy-6-oxo-1H-pyrimidin-2-yl)methyl]-2-(6-morpholin-4-yl-2-pyridin-2-ylpurin-7-yl)acetamide;6-methyl-2-pyridin-2-ylthieno[3,2-d]pyrimidin-4-amine;2-(6-morpholin-4-yl-2-pyridin-2-ylpurin-7-yl)acetamide;7-phenyl-2-pyridin-2-ylthieno[3,2-d]pyrimidin-4-amine;4-[2-pyridin-2-yl-5-(trifluoromethyl)thieno[2,3-d]pyrimidin-4-yl]morpholine is COc1cnc(CNC(=O)Cn2cnc3nc(-c4ccccn4)nc(N4CCOCC4)c32)[nH]c1=O.Cc1cc2nc(-c3ccccn3)nc(N)c2s1.FC(F)(F)c1csc2nc(-c3ccccn3)nc(N3CCOCC3)c12.NC(=O)Cn1cnc2nc(-c3ccccn3)nc(N3CCOCC3)c21.Nc1nc(-c2ccccn2)nc2c(-c3ccccc3)csc12.
What is the InChIKey of N-[(5-methoxy-6-oxo-1H-pyrimidin-2-yl)methyl]-2-(6-morpholin-4-yl-2-pyridin-2-ylpurin-7-yl)acetamide;6-methyl-2-pyridin-2-ylthieno[3,2-d]pyrimidin-4-amine;2-(6-morpholin-4-yl-2-pyridin-2-ylpurin-7-yl)acetamide;7-phenyl-2-pyridin-2-ylthieno[3,2-d]pyrimidin-4-amine;4-[2-pyridin-2-yl-5-(trifluoromethyl)thieno[2,3-d]pyrimidin-4-yl]morpholine?
The InChIKey is QYZXIRRBYACBRC-UHFFFAOYSA-N. The full InChI is InChI=1S/C22H23N9O4.C17H12N4S.C16H13F3N4OS.C16H17N7O2.C12H10N4S/c1-34-15-10-24-16(27-22(15)33)11-25-17(32)12-31-13-26-20-18(31)21(30-6-8-35-9-7-30)29-19(28-20)14-4-2-3-5-23-14;18-16-15-14(12(10-22-15)11-6-2-1-3-7-11)20-17(21-16)13-8-4-5-9-19-13;17-16(18,19)10-9-25-15-12(10)14(23-5-7-24-8-6-23)21-13(22-15)11-3-1-2-4-20-11;17-12(24)9-23-10-19-15-13(23)16(22-5-7-25-8-6-22)21-14(20-15)11-3-1-2-4-18-11;1-7-6-9-10(17-7)11(13)16-12(15-9)8-4-2-3-5-14-8/h2-5,10,13H,6-9,11-12H2,1H3,(H,25,32)(H,24,27,33);1-10H,(H2,18,20,21);1-4,9H,5-8H2;1-4,10H,5-9H2,(H2,17,24);2-6H,1H3,(H2,13,15,16).
What are the key properties of N-[(5-methoxy-6-oxo-1H-pyrimidin-2-yl)methyl]-2-(6-morpholin-4-yl-2-pyridin-2-ylpurin-7-yl)acetamide;6-methyl-2-pyridin-2-ylthieno[3,2-d]pyrimidin-4-amine;2-(6-morpholin-4-yl-2-pyridin-2-ylpurin-7-yl)acetamide;7-phenyl-2-pyridin-2-ylthieno[3,2-d]pyrimidin-4-amine;4-[2-pyridin-2-yl-5-(trifluoromethyl)thieno[2,3-d]pyrimidin-4-yl]morpholine?
N-[(5-methoxy-6-oxo-1H-pyrimidin-2-yl)methyl]-2-(6-morpholin-4-yl-2-pyridin-2-ylpurin-7-yl)acetamide;6-methyl-2-pyridin-2-ylthieno[3,2-d]pyrimidin-4-amine;2-(6-morpholin-4-yl-2-pyridin-2-ylpurin-7-yl)acetamide;7-phenyl-2-pyridin-2-ylthieno[3,2-d]pyrimidin-4-amine;4-[2-pyridin-2-yl-5-(trifluoromethyl)thieno[2,3-d]pyrimidin-4-yl]morpholine has a molecular weight of 1729.90 g/mol, XLogP of 10.60, 16 rotatable bonds, 5 hydrogen bond donors, and 35 hydrogen bond acceptors.
Where does this data come from?
All data for N-[(5-methoxy-6-oxo-1H-pyrimidin-2-yl)methyl]-2-(6-morpholin-4-yl-2-pyridin-2-ylpurin-7-yl)acetamide;6-methyl-2-pyridin-2-ylthieno[3,2-d]pyrimidin-4-amine;2-(6-morpholin-4-yl-2-pyridin-2-ylpurin-7-yl)acetamide;7-phenyl-2-pyridin-2-ylthieno[3,2-d]pyrimidin-4-amine;4-[2-pyridin-2-yl-5-(trifluoromethyl)thieno[2,3-d]pyrimidin-4-yl]morpholine is sourced from PubChem (CID 160558567), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).